ElevateBio Raises $150 Million

Want to share this story?


Amount: $150,000,000

Round: Series A

Investors  Lead: EcoR1 Capital, UBS Oncology Impact Fund

Others: F2 Ventures, Redmile Group, Samsara BioCapital

What startup does: Creates, operates portfolio of cell and gene therapy companies by partnering with leading academic researches, medical centers and entrephenuer.

Fund plans: to acquire new companies in its portfolio